Latest debt-to-equity ratio
Immunome Debt-to-equity ratio
Direct answer
Immunome's debt-to-equity ratio is 0.9%.
The verified market snapshot reports 0.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.9%